News
The analyst firm set a price target for $40.00 expecting SMA to rise to within 12 months (a possible 9.47% upside). 7 analyst firms have reported ratings in the last year. Analysts arrive at stock ...
1d
Zacks Investment Research on MSNBarrick Mining Eclipses 50-Day SMA: What Should Investors Do Now?Barrick Mining Corporation’s B stock broke out above its 50-day simple moving average (SMA) last Friday, flashing a bullish ...
SmartStop Self Storage REIT, Inc. ("SmartStop") (NYSE: SMA), an internally managed real estate investment trust and a premier ...
Jason Gerberry has given his Buy rating due to a combination of factors ... a myostatin inhibitor in its Phase 3 SMA trial, known as RESILIENT. Despite some risks associated with the broad ...
The adjustment followed the announcement made by Biohaven that its Phase 3 RESILIENT study of taldefgrobep alfa for Spinal Muscular Atrophy (SMA ... and sustained Buy rating, based on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results